NCT06207435Completed
Community Support Program for Lung Cancer Screening
Source: ClinicalTrials.gov · Last updated 2 Sept 2025
Brief summary (registry, in English)
The research study aims to create a program for lung cancer screening attendance
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 242 (actual)
- First submitted
- 20 Dec 2023
- Start date
- 10 Feb 2023
- Primary completion date
- 12 Aug 2024
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Diseases
- Lung cancer
- NCT number
- NCT06207435
What you commit to
- Study type: Interventional
- Participants enrolled: 242
- From 10 Feb 2023 to the primary completion date, 12 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Outside age range
Other
- No upcoming LDCT
- Lives outside West Philadelphia
Who the study is looking for
- Upcoming or missed follow-up LDCT (low dose CT)
- West Philadelphia resident
- Between 18-89 years' old
Age in the registry: 18 years to 89 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.